Search results
Jun 20, 2024 · Paxlovid, an oral antiviral pill that can be taken at home, is the go-to treatment for COVID-19. If you are at high risk for severe disease from COVID, and you take it within the first five days of experiencing symptoms, it will lower your risk of getting so sick that you need to be hospitalized.
Jul 8, 2024 · A Pfizer-led study supports the benefits of Paxlovid in COVID-19 patients who are at high risk for severe or prolonged disease, particularly older adults and those who are immunocompromised.
Jan 11, 2024 · As hospitalizations and deaths from Covid-19 rise, fueled by a fast-moving new variant that now accounts for a majority of U.S. cases, Paxlovid can help protect patients from some of the worst...
Jan 25, 2024 · Paxlovid is extremely effective when taken within five days of symptom onset. In clinical trials, it reduced the risk of hospitalization and death by almost 90% in unvaccinated people. “It’s a tremendous tool that's completely underutilized,” says Adalja.
Nov 15, 2023 · Paxlovid is effective at lowering the risk of hospitalization or death by 86% for adult patients who are at high risk of COVID-19 progressing to severe illness when Paxlovid is started within the first 3 days of COVID-19 symptoms.
Compared with placebos, both treatments were shown to be highly effective in clinical trials for reducing the risk of hospitalization and death—efficacy was 86% for nirmatrelvir-ritonavir and 87% for remdesivir. However, patients must go to an infusion center for 3 consecutive days to receive remdesivir intravenously.
Jun 7, 2024 · A five-day Paxlovid regimen has been shown to reduce recipients’ likelihood of hospitalization and death by more than 85%. While the Stanford trial did not show that Paxlovid reduced long COVID symptoms, it did show that taking the drug for more than two weeks was safe.
